Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-004708
Filing Date
2024-11-13
Accepted
2024-11-13 17:58:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 polar-avdl093024a1.htm SC 13G/A 86447
  Complete submission text file 0001172661-24-004708.txt   88103
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Subject) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 241455997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 16 PALACE STREET LONDON X0 SW1E 5JD
Business Address 16 PALACE STREET LONDON X0 SW1E 5JD 02072272700
Polar Capital Holdings Plc (Filed by) CIK: 0001837309 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SC 13G/A